GlassScriptPhysician profile
Rita M Catchings
NPI 1003567421
$383.37
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $295 · 2023: $17.61 · 2024: $71.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $84.23 | 2022-2023 | |
| Eisai INC. | $58.00 | 2022 | |
| Beigene USA, INC. | $47.65 | 2022-2024 | Brukinsa |
| Celgene Corporation | $44.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.94 | 2024 | Augtyro |
| Takeda Pharmaceuticals U.S.A., INC. | $27.02 | 2024 | Trintellix |
| Regeneron Healthcare Solutions, INC. | $21.33 | 2022 | |
| Merck Sharp & Dohme LLC | $19.71 | 2022 | |
| Daiichi Sankyo INC. | $18.81 | 2022 | |
| Morphosys, US INC. | $17.90 | 2022 | |
| Sobi, INC | $15.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Catchings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.